Antimalarial drug resistance: An overview
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Malaria is a major public health burden throughout the world. Resistance to the antimalarial drugs has increased the mortality and morbidity rate that is achieved so far through the malaria control program. Monitoring the drug resistance to the available antimalarial drugs helps to implement effective drug policy, through the in vivo efficacy studies, in vitro drug susceptibility tests and detection of molecular markers. It is important to understand the mechanism of the antimalarial drugs, as it is one of the key factors in the emergence and spread of drug resistance. This review summarizes the commonly used antimalarial drugs, their mechanism of action and the genetic markers validated so far for the detection of drug-resistant parasites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
Ashley, E. A., Dhorda, M., Fairhurst, R. M., Amaratunga, C., Lim, P., Suon, S., Sreng, S., Anderson, J. M., Mao, S., Sam, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314981 · Cited by 2,205 · cited 3×
“[11,36] Thus, polymorphism in K13 propeller protein is a potent molecular marker in determining the emergence and spread of artemisinin-resistant P. falciparum .”
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Ariey, F., Witkowski, B., Amaratunga, C., Beghain, J., Langlois, A.-C., Khim, N., Kim, S., Duru, V., Bouchier, C., Ma, L., et al. (2014) · Nature · doi:10.1038/nature12876 · Cited by 2,090 · cited 7×
“[36] M476I mutation in the kelch repeat no. 2 and D56V mutation in PF3D7_0110400 gene increased the artemisinin resistance in Tanzania.”
InfluentialEvidence of Artemisinin-Resistant Malaria in Western Cambodia
Noedl, H., Se, Y., Schaecher, K., Smith, B. L., Socheat, D., & Fukuda, M. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0805011 · Cited by 1,785
Fidock, D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00084-8 · Cited by 1,456
Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum
Reed, M. B., Saliba, K. J., Caruana, S. R., Kirk, K., & Cowman, A. F. (2000) · Nature · doi:10.1038/35002615 · Cited by 866
Peterson, D. S., Walliker, D., & Wellems, T. E. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9114 · Cited by 653
Foote, S. J., Thompson, J. K., Cowman, A. F., & Kemp, D. J. (1989) · Cell · doi:10.1016/0092-8674(89)90330-9 · Cited by 573 · cited 2×
“[49,50] Polymorphism, amplification, and variation in mRNA expression level of the Pfmdr1 gene have involved in resistance to various antimalarials and emergence of multi-drug resistance parasites.”
InfluentialCowman, A. F., Morry, M. J., Biggs, B. A., Cross, G. A., & Foote, S. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9109 · Cited by 526 · cited 1×
“[5,31,38,67]”
The public health impact of chloroquine resistance in Africa
Trape, J. (2001) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.12 · Cited by 521 · cited 1×
“[5,6] 7-9] Use of antimalarial drugs as combination therapy instead of monotherapy has been in practice to increase the efficacy of drug and to delay the emergence of drug resistance parasite.”
Mechanisms of Resistance of Malaria Parasites to Antifolates
Gregson, A., & Plowe, C. V. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.4 · Cited by 499 · cited 1×
“31-35] Whole genome sequencing of the artemisinin-resistant parasite revealed mutation in the Kelch 13 (K13) propeller protein associated with the artemisinin resistance in both clinical and field isolates.”
Sidhu, A. B. S., Gaw, S. L., & Fidock, D. A. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04729.x · Cited by 433
SAFETY AND EFFICACY OF A RECOMBINANT DNA PLASMODIUM FALCIPARUM SPOROZOITE VACCINE
Ripley Ballou, W., Hoffman, S. L., Sherwood, J. A., Hollingdale, M. R., Neva, F. A., Hockmeyer, W. T., Gordon, D. M., Schneider, I., Wirtz, R. A., Young, J. F., et al. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90540-x · Cited by 427
Sidhu, A. B. S., Uhlemann, A., Valderramos, S. G., Valderramos, J., Krishna, S., & Fidock, D. A. (2006) · The Journal of Infectious Diseases · doi:10.1086/507115 · Cited by 415 · cited 1×
“[55] PLASMODIUM FALCIPARUM MULTIDRUG RESISTANCE‑”
Tun, K. M., Imwong, M., Lwin, K. M., Win, A. A., Hlaing, T. M., Hlaing, T., Lin, K., Kyaw, M. P., Plewes, K., Faiz, M. A., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70032-0 · Cited by 414 · cited 1×
“[11,36,37] Molecular marker detection by polymerase chain reaction for drug resistance: Overcome the in vivo and in vitro tests used, many isolates and markers screened in a short time, samples collected and stored for prolonged duration can also be studied.”
Spread of chloroquine resistance in Plasmodium falciparum
Payne, D. (1987) · Parasitology Today · doi:10.1016/0169-4758(87)90147-5 · Cited by 382
Sisowath, C., Strömberg, J., Mårtensson, A., Msellem, M., Obondo, C., Björkman, A., & Gil, J. P. (2005) · The Journal of Infectious Diseases · doi:10.1086/427997 · Cited by 377
Korsinczky, M., Chen, N., Kotecka, B., Saul, A., Rieckmann, K., & Cheng, Q. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2100-2108.2000 · Cited by 371 · cited 1×
“[71,72] Single mutation at Y268N/S/C codon in the cytb gene associated with resistance to atovaquone in P. falciparum field isolates.”
Chloroquine Resistance in Plasmodium vivax
Baird, J. K. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4075-4083.2004 · Cited by 335 · cited 1×
“[21,22] ANTIMALARIALS USED AGAINST MALARIA Based on the mode of action, the antimalarial drugs were mainly classified into three groups: quinolone, antifolate, and artemisinin derivatives.”
Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7.
Wellems, T. E., Walker-Jonah, A., & Panton, L. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3382 · Cited by 310 · cited 1×
“[26] 27-30] Antifolate drugs, SP, inhibits P. falciparum dihydropteroate synthetase (PfDHPS) and P. falciparum bifunctional dihydrofolate reductase-thymidylate synthase (PfDHFR) enzyme involved in folate biosynthesis pathway.”
Yayon, A., Cabantchik, Z. I., & Ginsburg, H. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb02195.x · Cited by 310 · cited 1×
“[39] Several studies comparing the wild and mutant PfCRT allele expression showed less CQ accumulation in mutant PfCRT when compared to wild PfCRT [40,41] and this difference in CQ accumulation is due to the active transport mechanism of mutant PfCRT in the resistant parasite.”
A Selective Sweep Driven by Pyrimethamine Treatment in Southeast Asian Malaria Parasites
Nair, S. (2003) · Molecular Biology and Evolution · doi:10.1093/molbev/msg162 · Cited by 308 · cited 1×
“[5,6] 7-9] Use of antimalarial drugs as combination therapy instead of monotherapy has been in practice to increase the efficacy of drug and to delay the emergence of drug resistance parasite.”
(1972) · Medicinal Chemistry · doi:10.1016/b978-0-12-688950-5.50009-x · Cited by 301
Contribution of the pfmdr1 gene to antimalarial drug-resistance
Duraisingh, M. T., & Cowman, A. F. (2005) · Acta Tropica · doi:10.1016/j.actatropica.2005.04.008 · Cited by 300 · cited 3×
“[49,50] Polymorphism, amplification, and variation in mRNA expression level of the Pfmdr1 gene have involved in resistance to various antimalarials and emergence of multi-drug resistance parasites.”
InfluentialDrug‐resistant malaria: Molecular mechanisms and implications for public health
Petersen, I., Eastman, R., & Lanzer, M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.042 · Cited by 289 · cited 7×
“[62] Thus, repeat polymorphism in Pfnhe1 gene may be used as a valid genetic marker to determine the quinine resistance in some regions [5] and resistance to quinine also mediated by other genetic markers such as Pfcrt , Pfmrd1 , and Pfmrp .”
InfluentialResistance to Antimalarials in Southeast Asia and Genetic Polymorphisms in pfmdr1
Pickard, A. L., Wongsrichanalai, C., Purfield, A., Kamwendo, D., Emery, K., Zalewski, C., Kawamoto, F., Miller, R. S., & Meshnick, S. R. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2418-2423.2003 · Cited by 279 · cited 1×
“[50] 51-53] PfMDR1 mutations at N86Y and N1042D position have associated with AQ resistance.”
Wang, P., Lee, C.-S., Bayoumi, R., Djimde, A., Doumbo, O., Swedberg, G., Dao, L. D., Mshinda, H., Tanner, M., Watkins, W. M., et al. (1997) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(97)00114-x · Cited by 261
Suwanarusk, R., Russell, B., Chavchich, M., Chalfein, F., Kenangalem, E., Kosaisavee, V., Prasetyorini, B., Piera, K. A., Barends, M., Brockman, A., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001089 · Cited by 247 · cited 1×
“[5] [75-77] Pvcrt gene in P. vivax , a homolog of Pfcrt , have not been associated with CQ resistance unlike in P. falciparum where the mutation in this gene exhibit a higher degree of resistance.”
Drug‐resistant malaria − an insight
Hyde, J. E. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05999.x · Cited by 239 · cited 2×
“…whereas mutation at 437 and 540 contribute a low level of resistance with modulation effects in association with other mutation in PfDHPS. [69] Since the antimalarial drug resistance as monotherapy has emerged, sulfadoxine is always provided in combination with pyrimethamine, known as SP…”
Antifolate antimalarial resistance in southeast Africa: a population-based analysis
Roper, C., Pearce, R., Bredenkamp, B., Gumede, J., Drakeley, C., Mosha, F., Chandramohan, D., & Sharp, B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12951-0 · Cited by 237
Sisowath, C., Petersen, I., Veiga, M. I., Mårtensson, A., Premji, Z., Björkman, A., Fidock, D. A., & Gil, J. P. (2009) · Journal of Infectious Diseases · doi:10.1086/596738 · Cited by 231
Nomura, T., Carlton, J. M., Baird, J. K., Portillo, H. A. D., Fryauff, D. J., Rathore, D., Fidock, D. A., Su, X., Collins, W. E., McCutchan, T. F., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/320707 · Cited by 223 · cited 1×
“[78] MQ resistance in P. vivax has associated with amplification of Pvmdr1 gene.”
Raj, D. K., Mu, J., Jiang, H., Kabát, J., Singh, S., Sullivan, M., Fay, M. P., McCutchan, T. F., & Su, X. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806944200 · Cited by 183 · cited 3×
“[57] Thus, PfMRP is involved in varying the antimalarial response to resistance but not in determining the drug resistance mainly, and also hypothesized that PfMRP protein effluxes various metabolites and drugs out of the parasite in association with other transporters.”
The mode of action and the mechanism of resistance to antimalarial drugs
Foote, S. J., & Cowman, A. F. (1994) · Acta Tropica · doi:10.1016/0001-706x(94)90061-2 · Cited by 173 · cited 3×
“[5,64] Five mutations in the PfDHPS protein (S436A/F, A437G, L540E, A581G, and A613T/S) have linked with resistance to sulfadoxine in P. falciparum .”
Exploring the folate pathway in Plasmodium falciparum
Hyde, J. E. (2005) · Acta Tropica · doi:10.1016/j.actatropica.2005.04.002 · Cited by 167 · cited 1×
“[65] ,66-68] Double mutation at A16V and S108T positions in PfDHFR linked with the resistance of P. falciparum to cycloguanil.”
Antimalarial drug resistance: a review of the biology and strategies to delay emergence and spread
Klein, E. Y. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.12.007 · Cited by 155 · cited 1×
“[1,2] However, the therapeutic efficacy of CQ and efforts to eradicate malaria worldwide were diminished due to the occurrence of CQ resistance.”
Korsinczky, M. L. J., Fischer, K., Chen, N., Baker, J., Rieckmann, K. H., & Cheng, Q. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2214-2222.2004 · Cited by 142
Inhibiting Plasmodium cytochrome bc1: a complex issue
Barton, V., Fisher, N. E., Biagini, G. A., Ward, S. A., & O’Neill, P. M. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.05.005 · Cited by 135 · cited 2×
“[70] Ubiquinol binding site is a highly conserved region of the protein and mutation in this region confers atovaquone resistance.”
Influentialde Pécoulas, P. E., Tahar, R., Ouatas, T., Mazabraud, A., & Basco, L. K. (1998) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(97)00247-8 · Cited by 120 · cited 1×
“[77,79] [80-82] The wild type residue V585 in Pvdhps gene showed innate resistance to sulfadoxine and is enhanced by the mutation in A383G and A553G codons in PvDHPS, which is similar to PfDHPS mutation at codons A347G and A581G.”
Amplification of pvmdr1 Associated with Multidrug‐Resistant Plasmodium vivax
Suwanarusk, R., Chavchich, M., Russell, B., Jaidee, A., Chalfein, F., Barends, M., Prasetyorini, B., Kenangalem, E., Piera, K. A., Lek‐Uthai, U., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/592451 · Cited by 119 · cited 3×
“[77,79] [80-82] The wild type residue V585 in Pvdhps gene showed innate resistance to sulfadoxine and is enhanced by the mutation in A383G and A553G codons in PvDHPS, which is similar to PfDHPS mutation at codons A347G and A581G.”
Determinants of In Vitro Drug Susceptibility Testing of Plasmodium vivax
Russell, B., Chalfein, F., Prasetyorini, B., Kenangalem, E., Piera, K., Suwanarusk, R., Brockman, A., Prayoga, P., Sugiarto, P., Cheng, Q., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01334-07 · Cited by 118
Chloroquine-resistant Plasmodium malariae in south Sumatra, Indonesia
Maguire, J. D., Sumawinata, I. W., Masbar, S., Laksana, B., Prodjodipuro, P., Sismadi, P., Mahmud, N., Bangs, M. J., Baird, J. K., & Susanti, I. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09336-4 · Cited by 107
Advances in understanding the genetic basis of antimalarial drug resistance
Ekland, E. H., & Fidock, D. A. (2007) · Current Opinion in Microbiology · doi:10.1016/j.mib.2007.07.007 · Cited by 106
Vivax malaria resistant to chloroquine: case reports from Bombay
Garg, M., Gopinathan, N., Bodhe, P. V., & Kshirsagar, N. A. (1995) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(95)90432-8 · Cited by 103 · cited 1×
“[21,22] ANTIMALARIALS USED AGAINST MALARIA Based on the mode of action, the antimalarial drugs were mainly classified into three groups: quinolone, antifolate, and artemisinin derivatives.”
Farooq, U., & Mahajan, R. (1971) · The Lancet · doi:10.1016/s0140-6736(71)90227-3 · Cited by 87
Plasmodium falciparum Na+/H+ exchanger activity and quinine resistance
Bennett, T. N., Patel, J., Ferdig, M. T., & Roepe, P. D. (2007) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2007.01.018 · Cited by 86 · cited 1×
“[60] The role of PfNHE was not understood fully but hypothesized that it is involved in active efflux of protons to maintain pH 7.4 within the parasite, in response to acidification by anaerobic glycolysis, the primary energy source for the parasite.”
InfluentialMolecular markers for drug resistance in malaria: use in treatment, diagnosis and epidemiology
Wernsdorfer, W. H., & Noedl, H. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200312000-00007 · Cited by 81 · cited 2×
“[65] ,66-68] Double mutation at A16V and S108T positions in PfDHFR linked with the resistance of P. falciparum to cycloguanil.”
Resistance to chloroquine in falciparum malaria in Assam State, India.
Sehgal, P. N., Sharma, M. I. D., Sharma, S., & Gogai, S. (1973) · JOURNAL OF COMMUNICABLE DISEASES · Cited by 79
Kinetic characterization of Na+/H+ antiport of Plasmodium falciparum membrane
Bosìa, A., Ghigo, D., Turrini, F. M., Nissani, E., Pescarmona, G., & Ginsburg, H. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041540311 · Cited by 79 · cited 1×
“[61] In field and in vitro culture studies, polymorphism in the microsatellite ms470 region exhibited a decrease in quinine susceptibility with an increase in DNNND repeat motif whereas increase in quinine susceptibility observed with a rise in NHNDNHNNDDD motif.”
The mechanism of resistance to sulfa drugs in Plasmodium falciparum
Triglia, T., & Cowman, A. F. (1999) · Drug Resistance Updates · doi:10.1054/drup.1998.0060 · Cited by 67
Parija, S., & Praharaj, I. (2011) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.83906 · Cited by 52 · cited 1×
“[1,2] However, the therapeutic efficacy of CQ and efforts to eradicate malaria worldwide were diminished due to the occurrence of CQ resistance.”
Self-citationMénard, D., Yapou, F., Manirakiza, A., Djallé, D., Matsika-Claquin, M. D., & Talarmin, A. (2006) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2006.75.381 · Cited by 44
Urdaneta-Márquez, L., Plowe, C. V., Goldman, I. F., & Lal, A. A. (1999) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1999.61.457 · Cited by 37 · cited 1×
“[5,31,38,67]”
Understanding drug resistance in malaria parasites: Basic science for public health
Sibley, C. H. (2014) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2014.06.001 · Cited by 37 · cited 2×
“[36,73] The kelch family proteins have diverse cellular functions, such as in organizing and interacting with other proteins.”
Cited by
Biological Activities of Essential Oils: From Plant Chemoecology to Traditional Healing Systems
Sharifi-Rad, J., Sureda, A., Tenore, G., Daglia, M., Sharifi-Rad, M., Valussi, M., Tundis, R., Sharifi-Rad, M., Loizzo, M., Ademiluyi, A., et al. (2017) · Molecules · doi:10.3390/molecules22010070 · Cited by 889
“In this way, Plasmodium falciparum and Leishmania donovani are protozoan parasites which are becoming resistant to conventional drugs, and this leads to an increase of the mortality and morbidity rates [127,128].”
Background
Metadata
- Authors
- Parija, S., & Antony, H.
- Venue
- Tropical Parasitology
- Publisher
- Medknow
- Published
- 2016
- Volume
- 6
- Issue
- 1
- Pages
- 30
- ISSN
- 0000-0205 (ISSN-L)
- 2229-5070
- OpenAlex
- W2310737069
- Cited by
- 215
- References
- 53
- FWCI
- 19.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.